0001609351-17-000106.txt : 20170920
0001609351-17-000106.hdr.sgml : 20170920
20170920162712
ACCESSION NUMBER: 0001609351-17-000106
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170919
FILED AS OF DATE: 20170920
DATE AS OF CHANGE: 20170920
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Faga Daniel
CENTRAL INDEX KEY: 0001673528
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36819
FILM NUMBER: 171094261
MAIL ADDRESS:
STREET 1: 3737 MARKET STREET
STREET 2: SUITE 1300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Spark Therapeutics, Inc.
CENTRAL INDEX KEY: 0001609351
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 462654405
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3737 MARKET STREET
STREET 2: SUITE 1300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
BUSINESS PHONE: 888-772-7560
MAIL ADDRESS:
STREET 1: 3737 MARKET STREET
STREET 2: SUITE 1300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
4
1
wf-form4_150593921639753.xml
FORM 4
X0306
4
2017-09-19
0
0001609351
Spark Therapeutics, Inc.
ONCE
0001673528
Faga Daniel
3737 MARKET STREET
SUITE 1300
PHILADELPHIA
PA
19104
0
1
0
0
Chief Business Officer
Common Stock
2017-09-19
4
M
0
1500
37.62
A
1500
D
Common Stock
2017-09-19
4
S
0
1500
85
D
0
D
Employee Stock Option (right to buy)
37.62
2017-09-19
4
M
0
1500
0
D
2026-05-01
Common Stock
1500.0
137500
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2017.
25% vested May 2, 2017 and the remainder vests in equal quarterly installments over the following three years.
/s/ Joseph W. La Barge, attorney-in-fact for Daniel R. Faga
2017-09-20